Related Experiment Video

Updated: Oct 18, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.0K

Controversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic Results

Arif Sarowar1, Grishma Hirode1, Harry L A Janssen1

  • 1Toronto Centre for Liver Disease, University Health Network, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada.

Clinics in Liver Disease
|October 1, 2021
PubMed

Insights

Hepatitis B virus (HBV) infection can present with unusual serologic results, potentially leading to misclassification. Recognizing these discordant findings is key for accurate diagnosis and effective hepatitis B management.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Diagnostics

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern, despite available vaccines and treatments.
  • Current diagnostic strategies involve serologic, virologic, and biochemical markers to stage chronic HBV.
  • Ambiguities in serologic results can arise, complicating accurate patient classification.

Purpose of the Study:

  • To describe common discordant serologic results in chronic hepatitis B virus infection.
  • To explain the potential causes and clinical implications of these atypical findings.
  • To provide guidance on managing patients with discordant serologic profiles.

Main Methods:

  • Review of commonly encountered discordant serologic profiles in chronic HBV infection.
  • Analysis of the frequency, underlying mechanisms, and clinical significance of these discordant results.
  • Formulation of recommendations for clinical management based on identified patterns.

Main Results:

  • Identified specific scenarios of discordant serologic results that deviate from typical chronic HBV profiles.
  • Discussed the frequency of occurrence for each discordant scenario.
  • Provided etiological explanations and clinical management strategies for each case.

Conclusions:

  • Discordant serologic results in chronic hepatitis B virus infection can lead to misclassification if not properly recognized.
  • Understanding and identifying these atypical patterns are essential for precise clinical decision-making.
  • Effective management of chronic HBV requires careful interpretation of all diagnostic markers.

Keywords:
Chronic infectionDiscordant serologiesHepatitis BOccult hepatitis

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

40.9K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
28
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
143
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
26
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K